Summary:
- This article discusses the research and development (R&D) transformation at Neurocrine Biosciences, a leading biopharmaceutical company focused on developing innovative treatments for neurological and endocrine disorders.
- The company is showcasing its efforts to drive innovation across its neuroscience and endocrinology pipelines, including the development of new therapies for movement disorders, psychiatric conditions, and hormone-related diseases.
- Neurocrine Biosciences is leveraging its scientific expertise and advanced technologies to address unmet medical needs and improve the lives of patients suffering from complex neurological and endocrine conditions.